31% Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a ETESIAN Clinical Study of Briquilimab in Asthma Get link Facebook X Pinterest Email Other Apps GlobeNewswire Get link Facebook X Pinterest Email Other Apps